These effects, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two assist the strategy of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for opioid-linked disorders. (3) Besides if the patient https://orlandoh245byn9.worldblogged.com/profile